| LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT05321420) | PureTech | 2022-07-22 |
| Xenon MRI and Progressive ILD (NCT05241275) | Duke University | 2022-07-19 |
| Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) (NCT05621252) | Pliant Therapeutics, Inc. | 2022-07-13 |
| Pulmonary Fibrosis Foundation Community Registry (NCT05382572) | Pulmonary Fibrosis Foundation | 2022-07-11 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF (NCT05016817) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-07-03 |
| A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis (NCT05424887) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2022-07-01 |
| First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects (NCT05427253) | Vicore Pharma AB | 2022-06-08 |
| RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT05373914) | Blade Therapeutics | 2022-05-31 |
| 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study (NCT04677426) | University of Kansas Medical Center | 2022-05-01 |
| Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF). (NCT05052229) | Dr. Denis O'Donnell | 2022-04-21 |
| Palliative Care Planner (PCplanner) (NCT05095363) | Duke University | 2022-03-16 |
| Effects of Home-based Inspiratory Muscle Training in Patients With IPF (NCT05353556) | Dokuz Eylul University | 2022-02-21 |
| Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis (NCT05130970) | CSL Behring | 2022-02-03 |
| A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis (NCT05032066) | Amgen | 2022-01-20 |
| Development of Airway Absorption Sampling Methods (NCT04494334) | Imperial College London | 2022-01-01 |
| Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy Participants (NCT05134727) | AstraZeneca | 2021-11-18 |
| A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015 (NCT05022771) | Pulmongene Ltd. | 2021-10-14 |
| Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland (NCT06702228) | Royal College of Surgeons, Ireland | 2021-09-28 |
| A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 (NCT04540770) | HuniLife Biotechnology, Inc. | 2021-08-31 |
| A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis (NCT04594707) | Hoffmann-La Roche | 2021-08-30 |
| A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT04968574) | Endeavor Biomedicines, Inc. | 2021-08-26 |
| Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients (NCT05022784) | Boehringer Ingelheim | 2021-08-23 |
| A Trial of SHR - 1906 in Healthy Subjects (NCT04986540) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2021-08-10 |
| Interstitial Lung Disease Research Unit Biobank (NCT05392881) | University of Kansas Medical Center | 2021-08-09 |
| To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers (NCT04888728) | Daewoong Pharmaceutical Co. LTD. | 2021-06-30 |
| Phase ll Study of HEC585 in Patients With IPF (NCT05060822) | Sunshine Lake Pharma Co., Ltd. | 2021-06-30 |
| Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects (NCT07588646) | Sunshine Lake Pharma Co., Ltd. | 2021-06-29 |
| To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers (NCT05383131) | Sunshine Lake Pharma Co., Ltd. | 2021-06-23 |
| Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole (NCT04965298) | Norfolk and Norwich University Hospitals NHS Foundation Trust | 2021-06-16 |
| Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (NCT04708782) | United Therapeutics | 2021-06-01 |
| A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers (NCT04931147) | Redx Pharma Ltd | 2021-05-13 |
| IPF mHealth Exercise Study (NCT04838275) | University of Washington | 2021-05-01 |
| Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary Fibrosis (NCT04619199) | Assistance Publique - Hôpitaux de Paris | 2021-04-01 |
| To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers (NCT04767815) | Daewoong Pharmaceutical Co. LTD. | 2021-03-22 |
| A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis (NCT04552899) | Hoffmann-La Roche | 2021-03-19 |
| Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT04643769) | Orinove, Inc. | 2021-02-09 |
| Longitudinal Changes in Serum KL-6 in IPF (NCT04268485) | Manchester University NHS Foundation Trust | 2021-02-01 |
| Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis (NCT02848625) | University of Washington | 2021-01-27 |
| NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib (NCT04614441) | Boehringer Ingelheim | 2021-01-21 |
| Safety and Effectiveness of Nintedanib in Korean Patients (NCT04525547) | Boehringer Ingelheim | 2021-01-13 |
| Medication Adherence and Non-adherence in Adults With Rare Disease (NCT04541875) | Xperiome | 2021-01-01 |
| Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial (NCT04300920) | Fernando J Martinez | 2020-12-17 |
| Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis Cough (NCT04429516) | Royal Brompton & Harefield NHS Foundation Trust | 2020-12-17 |
| Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases (NCT06909968) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2020-12-14 |
| Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis (NCT04362644) | University of Alabama at Birmingham | 2020-12-08 |
| Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF (NCT04533022) | Vicore Pharma AB | 2020-11-13 |
| Reliability and Validity of iOS in IPF (NCT04572971) | Royal Brompton & Harefield NHS Foundation Trust | 2020-11-06 |
| Changes in iOS in IPF (NCT04572958) | Royal Brompton & Harefield NHS Foundation Trust | 2020-11-06 |
| Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases (NCT04693975) | Universidade Estadual de Londrina | 2020-10-16 |
| Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT04419558) | Kyntra Bio | 2020-09-30 |
| Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis (NCT04312594) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2020-09-08 |
| GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis (NCT03865927) | University of Alabama at Birmingham | 2020-09-07 |
| Genentech Xenon MRI Idiopathic Pulmonary Fibrosis (NCT04071769) | Duke University | 2020-08-03 |
| Inspiratory Muscle Training in Patients With Interstitial Lung Disease (NCT04481074) | Federal University of Minas Gerais | 2020-07-30 |
| Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough (NCT04318704) | Algernon Pharmaceuticals | 2020-07-29 |
| A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) (NCT04419506) | Boehringer Ingelheim | 2020-07-28 |
| Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects (NCT04512170) | Sunshine Lake Pharma Co., Ltd. | 2020-07-13 |
| Cohort of IPF Patients Experiencing an Exacerbation (NCT04442711) | University Hospital, Gentofte, Copenhagen | 2020-06-13 |
| 23andMe IPF Research Study (NCT05028894) | 23andMe, Inc. | 2020-06-05 |
| Heart Rate Variability and Nocturnal Blood Oxygen Saturation in Patients With Idiopathic Pulmonary Fibrosis (NCT06027372) | Taipei Veterans General Hospital, Taiwan | 2020-05-21 |
| Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection (NCT04326036) | Black Tie Medical, Inc. | 2020-03-25 |
| Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis (NCT04396756) | Pliant Therapeutics, Inc. | 2020-03-03 |
| A Study of Patients With Chronic Disease (NCT04263727) | Target PharmaSolutions, Inc. | 2020-02-27 |
| Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/ (NCT04072315) | Pliant Therapeutics, Inc. | 2020-02-13 |
| Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD (NCT04257630) | Schön Klinik Berchtesgadener Land | 2020-02-06 |
| Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving Pirfenidone (NCT03692481) | Assistance Publique - Hôpitaux de Paris | 2020-02-04 |
| Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy) (NCT03901196) | University Hospital, Grenoble | 2020-01-22 |
| Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects (NCT04233814) | Rein Therapeutics | 2020-01-20 |
| Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF (NCT04244825) | Blade Therapeutics | 2019-12-15 |
| Effect of Core Stabilization Exercises and Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis (NCT04197791) | Istanbul University - Cerrahpasa | 2019-12-10 |
| A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects (NCT04720443) | The National Institutes of Pharmaceutical R&D Co. Ltd, China | 2019-11-22 |
| A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough (NCT04030026) | Trevi Therapeutics | 2019-10-29 |
| Cardiovascular Fibrosis in Idiopathic Pulmonary Fibrosis (NCT04177251) | San Gerardo Hospital | 2019-10-21 |
| Health and Quality of Life Assessment Project for Caregivers of Idiopathic Pulmonary Fibrosis Patients (NCT04031690) | Centre Hospitalier Universitaire Dijon | 2019-10-14 |
| Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF (NCT05359965) | University of Arizona | 2019-10-01 |
| Quality of Life in IPF - Patient and Physician Perceptions (NCT04148157) | University of Washington | 2019-09-23 |
| Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects (NCT03562416) | Temple University | 2019-07-05 |
| Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study (NCT03836417) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-06-28 |
| Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT03955146) | Kyntra Bio | 2019-06-18 |
| ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution (NCT03944928) | University Hospital, Tours | 2019-06-11 |
| Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis (NCT03898284) | University Hospital, Tours | 2019-04-23 |
| A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis (NCT03949530) | Indalo Therapeutics, Inc. | 2019-04-16 |
| Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes (NCT04316780) | Steward St. Elizabeth's Medical Center of Boston, Inc. | 2019-04-15 |
| Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis (NCT03890250) | Biruni University | 2019-03-20 |
| High-flow Oxygen Therapy During Exercise in Idiopathic Pulmonary Fibrosis (NCT04564664) | Parc de Salut Mar | 2019-03-01 |
| Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib (NCT03710824) | Boehringer Ingelheim | 2019-02-28 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects (NCT03830125) | Bridge Biotherapeutics, Inc. | 2019-02-13 |
| A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking (NCT03958071) | Boehringer Ingelheim | 2019-02-01 |
| Impact of Air Pollution on Chronic Respiratory Diseases (NCT03813810) | Seoul National University Hospital | 2019-01-25 |
| BPF Genetics of ILD Study (NCT03747627) | University of Dundee | 2019-01-19 |
| Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden (NCT04019080) | Karolinska University Hospital | 2019-01-01 |
| FIBRotic Interstitial Lung Disease and Nocturnal OXygen (NCT04586946) | Guy's and St Thomas' NHS Foundation Trust | 2018-12-17 |
| Nutritional Assessment in Idiopathic Pulmonary Fibrosis (NCT03770845) | San Gerardo Hospital | 2018-12-10 |
| Outcome of Idiopathic Pulmonary Fibrosis With Pregnancy (NCT04775277) | Sohag University | 2018-12-01 |
| Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis (NCT03744598) | patientMpower Ltd. | 2018-11-28 |
| Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis (NCT03727802) | Toray Industries, Inc | 2018-11-28 |
| A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care (NCT03711162) | Lakefront Biotherapeutics NV | 2018-11-28 |
| Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT03717012) | Boehringer Ingelheim | 2018-11-15 |
| It's Not JUST Idiopathic Pulmonary Fibrosis Study (NCT03670576) | University of Nottingham | 2018-11-11 |
| Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis (NCT03258801) | Dr. Christopher Lambers | 2018-10-29 |